<bill session="113" type="h" number="4918" updated="2015-09-01T10:20:46-04:00">
  <state datetime="2014-06-19">REFERRED</state>
  <status>
    <introduced datetime="2014-06-19"/>
  </status>
  <introduced datetime="2014-06-19"/>
  <titles>
    <title type="short" as="introduced">Speeding Access to Already Approved Pharmaceuticals Act of 2014</title>
    <title type="official" as="introduced">To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.</title>
  </titles>
  <sponsor id="412461"/>
  <cosponsors>
    <cosponsor id="400352" joined="2014-06-19"/>
  </cosponsors>
  <actions>
    <action datetime="2014-06-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary>6/19/2014--Introduced.
Speeding Access to Already Approved Pharmaceuticals Act of 2014 - Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA), under procedures for expedited approval of products to treat a serious or life-threatening disease or condition, to facilitate the development and expedite the review of new drugs or devices approved for marketing in the European Union.</summary>
</bill>
